Brodalumab Subcutaneous and Linagliptin and Metformin Extended-Release Tablets
Determining the interaction of Brodalumab Subcutaneous and Linagliptin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Linagliptin and Metformin Tablets
- Brodalumab Subcutaneous-Lincocin
- Brodalumab Subcutaneous-Lincomycin
- Brodalumab Subcutaneous-Lincomycin Hydrochloride
- Brodalumab Subcutaneous-Lincomycin Injection
- Brodalumab Subcutaneous-Lincomycin Oral, Injection
- Linagliptin and Metformin Extended-Release Tablets-Brodspec
- Linagliptin and Metformin Extended-Release Tablets-Brom Mal Phenyl HCl Dex HBr
- Linagliptin and Metformin Extended-Release Tablets-Bromaline
- Linagliptin and Metformin Extended-Release Tablets-Bromaline DM
- Linagliptin and Metformin Extended-Release Tablets-Bromatan Plus
- Linagliptin and Metformin Extended-Release Tablets-Bromatan-DM